Taro and Sun continue war of words
This article was originally published in Scrip
Executive Summary
The war of words between Sun Pharmaceutical Industries and its acquisition target, Taro Pharmaceutical Industries, continues, with Taro now warning shareholders of a possible "proxy fight" that Sun may wage to gain control of Taro’s board.